Cannabis consolidation is accelerating, but Seth Yakatan doesn’t see all M&A strategies as equal.
The veteran dealmaker and cannabis industry advisor sees two executives making particularly aggressive moves: Curaleaf Executive Chairman Boris Jordan and Vireo Growth CEO John Mazarakis.
The cannabis industry does not have a capital problem in the way many operators like to describe it. Capital still exists. Debt remains available to qualified operators, lenders continue to evaluate deals, and investors have not abandoned the space.
Cannabis stocks have rebounded sharply over the last twelve months. The AdvisorShares Pure US Cannabis ETF, MSOS, has climbed roughly 104% year-over-year, while the S&P 500 is up about 28% over the same period. On the surface, the sector appears to be recovering.
